STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021				$ (3,680,267)	$ (3,680,267)
Beginning balance (in shares) at Dec. 31, 2021
Fair value of shares issued in contribution agreement	$ 111	$ 60	1,889,400		1,900,000
Fair value of shares issued in contribution agreement (in shares)	10,000,000	600,000
Net contributions from Chromocell Corporation			422,173		422,173
Stock-based compensation			110,146		110,146
Net loss				(2,458,589)	(2,458,589)
Ending balance, value at Dec. 31, 2022	$ 1	$ 60	2,421,719	(6,138,856)	(3,706,537)
Ending balance (in shares) at Dec. 31, 2022	10,000,000	600,000
Fair value of shares issued in contribution agreement
Stock-based compensation			1,733,233		1,733,233
Net loss				(7,380,793)	(7,380,793)
Shares issued for extension of bridge loan	$ 2		428,398		428,400
Shares issued for extension of bridge loan (in shares)	18,892
Shares issued for license	$ 38		2,225,695		2,225,733
Shares issued for license (in shares)	384,226
Shares issued for cash	$ 253		255,159		255,412
Shares issued for cash (in shares)	2,533,853
Shares forfeited	$ (13)		13
Shares forfeited (in shares)	(133,745)
Ending balance, value at Dec. 31, 2023	$ 391	$ 60	$ 7,074,646	$ (13,519,649)	$ (6,444,552)
Ending balance (in shares) at Dec. 31, 2023	3,914,338	600,000